UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs

Cancers, 2023-11, Vol.15 (23), p.5546

2023

Volltextzugriff (PDF)

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET

EJNMMI research, 2024-02, Vol.14 (1), p.18-18, Article 18

2024

Volltextzugriff (PDF)

In memoriam: Marion Hendriks-de Jong

European journal of nuclear medicine and molecular imaging, 2021-09, Vol.48 (10), p.3026-3028

2021

Volltextzugriff (PDF)

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach

Oncotarget, 2017-01, Vol.8 (3), p.3870-3880

2017

Volltextzugriff (PDF)

How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans

EJNMMI physics, 2024-02, Vol.11 (1), p.16-16, Article 16

2024

Volltextzugriff (PDF)

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

EJNMMI radiopharmacy and chemistry, 2019-01, Vol.4 (1), p.2-2, Article 2

2019

Volltextzugriff (PDF)

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PloS one, 2014-01, Vol.9 (1), p.e82331

2014

Volltextzugriff (PDF)

PET Imaging of Microglial Activation-Beyond Targeting TSPO

Molecules (Basel, Switzerland), 2018-03, Vol.23 (3), p.607

2018

Volltextzugriff (PDF)

Towards PET imaging of the dynamic phenotypes of microglia

Clinical and experimental immunology, 2021-12, Vol.206 (3), p.282-300

2021

Volltextzugriff (PDF)

Study of 89 Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer

Journal of Nuclear Medicine, 2022-03, Vol.63 (3), p.362-367

2022

Volltextzugriff (PDF)

Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography

Biochimica et biophysica acta, 2016-03, Vol.1862 (3), p.425-441

2016

Volltextzugriff (PDF)

Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake

European journal of nuclear medicine and molecular imaging, 2023-06, Vol.50 (7), p.1897-1905

2023

Volltextzugriff (PDF)

The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

European journal of nuclear medicine and molecular imaging, 2020-02, Vol.47 (2), p.379-389

2020

Volltextzugriff (PDF)

Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice

PloS one, 2017-04, Vol.12 (4), p.e0176075-e0176075

2017

Volltextzugriff (PDF)

Improving Routine 89Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO

Journal of labelled compounds & radiopharmaceuticals, 2024-06, Vol.67 (8), p.280-287

2024

Volltextzugriff (PDF)

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (4), p.450

2022

Volltextzugriff (PDF)

Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs

Cancers, 2023-11, Vol.15 (23)

2023

Volltextzugriff (PDF)

State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis

EJNMMI radiopharmacy and chemistry, 2023-10, Vol.8 (1), p.28-28, Article 28

2023

Volltextzugriff (PDF)

PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139

Journal of neuroinflammation, 2020-10, Vol.17 (1), p.1-18, Article 300

2020

Volltextzugriff (PDF)

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

BMC cardiovascular disorders, 2022-02, Vol.22 (1), p.49-16, Article 49

2022

Volltextzugriff (PDF)

F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach

Molecular pharmaceutics, 2019-01, Vol.16 (1), p.273-281

2019

Volltextzugriff (PDF)

Synthesis of 18F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography

Angewandte Chemie International Edition, 2024-07, Vol.63 (27), p.e202404278-n/a

International ed. in English, 2024

Volltextzugriff (PDF)

Synthesis of 18F-labelled aryl trifluoromethyl ketones with improved molar activity

Chemical communications (Cambridge, England), 2024-06, Vol.60 (53), p.6801-6804

2024

Volltextzugriff (PDF)

Efficient synthesis of [18F]trifluoromethane and its application in the synthesis of PET tracers

Chemical communications (Cambridge, England), 2013-01, Vol.49 (38), p.4018-4020

2013

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(176)

Publikationsform

Artikel
(177)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(61)
Humans
(48)
Positron Emission Tomography
(31)
Tomography
(31)
Positron Emission
(29)
Imaging
(28)
Monoclonal Antibodies
(28)
Chemistry
(27)
Physical Sciences
(27)
Radiology, Nuclear Medicine & Medical Imaging
(26)
Nuclear Medicine
(25)
Animals
(24)
Oncology
(23)
Positron-Emission Tomography - Methods
(23)
Tumors
(22)
Radiology
(21)
Medicine
(19)
Medicine & Public Health
(19)
Radiochemistry
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET

In memoriam: Marion Hendriks-de Jong

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach

How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PET Imaging of Microglial Activation-Beyond Targeting TSPO

Towards PET imaging of the dynamic phenotypes of microglia

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Study of 89 Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer

Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography

Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake

The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice

Improving Routine 89Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs

State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis

PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach

Synthesis of 18F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography

Synthesis of 18F-labelled aryl trifluoromethyl ketones with improved molar activity

Efficient synthesis of [18F]trifluoromethane and its application in the synthesis of PET tracers

Suchergebnisse filtern